# Sio Capital Management, LLC 13F Q2 2026: $604 million

Sio Capital Management, LLC reported $604 million in 13F securities across 59 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Anteris Technologies Global at $54.6 million, 9.0% of the reported value. Since Q1 2026 it opened 17 new positions and exited 34.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $604,294,540
- Positions: 59
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1482416
- Form 13F file number: 028-13691
- Business address: 600 Third Avenue 2nd Floor, New York, NY 10016
- SEC filing: [0001214659-26-010311](https://www.sec.gov/Archives/edgar/data/1482416/000121465926010311/0001214659-26-010311-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/sio-capital-management-llc-165989)

## Top 25 holdings by value

The largest of 59 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Anteris Technologies Global](https://specstream.ai/data/institutional-holders/anteris-technologies-global-03675p102) | COM | 5,545,984 | $54.6 million | +163,019 |
| [Cencora Inc](https://specstream.ai/data/institutional-holders/cencora-inc-03073e105) | COM | 173,588 | $49.1 million | +72,694 |
| [Maximus Inc](https://specstream.ai/data/institutional-holders/maximus-inc-577933104) | COM | 715,267 | $38.5 million | -53,558 |
| [Allogene Therapeutics Inc](https://specstream.ai/data/institutional-holders/allogene-therapeutics-inc-019770106) | COM | 13,323,431 | $27.7 million | New |
| [Globus Med Inc](https://specstream.ai/data/institutional-holders/globus-med-inc-379577208) | CL A | 301,816 | $23.8 million | New |
| [GSK PLC](https://specstream.ai/data/institutional-holders/gsk-plc-37733w204) | SPONSORED ADR | 436,700 | $22.9 million | +50,821 |
| [Tyra Biosciences Inc](https://specstream.ai/data/institutional-holders/tyra-biosciences-inc-90240b106) | COM | 695,315 | $22.2 million | +89,876 |
| [Waystar HLDG Corp](https://specstream.ai/data/institutional-holders/waystar-hldg-corp-946784105) | COM | 925,834 | $19 million | -716,402 |
| Sellas Life Sciences Group I | COM NEW (put) | 1,230,700 | $18.2 million | New |
| [Ideaya Biosciences Inc](https://specstream.ai/data/institutional-holders/ideaya-biosciences-inc-45166a102) | COM | 480,383 | $17.9 million | New |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 177,118 | $16.9 million | +44,622 |
| [The Cigna Group](https://specstream.ai/data/institutional-holders/the-cigna-group-125523100) | COM | 57,750 | $15.9 million | New |
| [Sanofi SA](https://specstream.ai/data/institutional-holders/sanofi-sa-80105n105) | SPONSORED ADR | 364,200 | $15.5 million | +124,529 |
| [Icon PLC](https://specstream.ai/data/institutional-holders/icon-plc-g4705a100) | SHS | 88,186 | $15.3 million | -218,172 |
| [Viatris Inc](https://specstream.ai/data/institutional-holders/viatris-inc-92556v106) | COM | 954,299 | $15.2 million | New |
| [Cross Ctry Healthcare Inc](https://specstream.ai/data/institutional-holders/cross-ctry-healthcare-inc-227483104) | COM | 1,098,393 | $14.5 million | No change |
| [Rapport Therapeutics Inc](https://specstream.ai/data/institutional-holders/rapport-therapeutics-inc-75383l102) | COM | 307,657 | $12.8 million | -59,152 |
| [Abbott Laboratories](https://specstream.ai/data/institutional-holders/abbott-laboratories-002824100) | COM | 128,656 | $11.7 million | -57,918 |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 110,022 | $11.5 million | -83,821 |
| [Zimmer Biomet Holdings Inc](https://specstream.ai/data/institutional-holders/zimmer-biomet-holdings-inc-98956p102) | COM | 131,445 | $11.3 million | +68,832 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/institutional-holders/regeneron-pharmaceuticals-75886f107) | COM | 18,000 | $11.2 million | New |
| [Bristol-Myers Squibb Co](https://specstream.ai/data/institutional-holders/bristol-myers-squibb-co-110122108) | COM | 193,500 | $11.1 million | New |
| [Medtronic PLC](https://specstream.ai/data/institutional-holders/medtronic-plc-g5960l103) | SHS | 142,500 | $11.1 million | New |
| [Vir Biotechnology Inc](https://specstream.ai/data/institutional-holders/vir-biotechnology-inc-92764n102) | COM | 1,075,274 | $11 million | -423,346 |
| [Senseonics Hldgs Inc](https://specstream.ai/data/institutional-holders/senseonics-hldgs-inc-81727u303) | COM | 1,592,692 | $9 million | +1,476,908 |

## New positions in Q2 2026

17 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Allogene Therapeutics Inc](https://specstream.ai/data/institutional-holders/allogene-therapeutics-inc-019770106) | COM | 13,323,431 | $27.7 million |
| [Globus Med Inc](https://specstream.ai/data/institutional-holders/globus-med-inc-379577208) | CL A | 301,816 | $23.8 million |
| Sellas Life Sciences Group I | COM NEW (put) | 1,230,700 | $18.2 million |
| [Ideaya Biosciences Inc](https://specstream.ai/data/institutional-holders/ideaya-biosciences-inc-45166a102) | COM | 480,383 | $17.9 million |
| [The Cigna Group](https://specstream.ai/data/institutional-holders/the-cigna-group-125523100) | COM | 57,750 | $15.9 million |
| [Viatris Inc](https://specstream.ai/data/institutional-holders/viatris-inc-92556v106) | COM | 954,299 | $15.2 million |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/institutional-holders/regeneron-pharmaceuticals-75886f107) | COM | 18,000 | $11.2 million |
| [Bristol-Myers Squibb Co](https://specstream.ai/data/institutional-holders/bristol-myers-squibb-co-110122108) | COM | 193,500 | $11.1 million |
| [Medtronic PLC](https://specstream.ai/data/institutional-holders/medtronic-plc-g5960l103) | SHS | 142,500 | $11.1 million |
| [Cybin Inc](https://specstream.ai/data/institutional-holders/cybin-inc-23256x407) | COM NEW | 1,300,000 | $8.6 million |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 208,500 | $6.5 million |
| [Aveanna Healthcare Hldgs Inc](https://specstream.ai/data/institutional-holders/aveanna-healthcare-hldgs-inc-05356f105) | COM | 369,036 | $3.2 million |
| Hims & Hers Health Inc | COM CL A (call) | 75,000 | $2.6 million |
| [Artivion Inc](https://specstream.ai/data/institutional-holders/artivion-inc-228903100) | COM | 48,481 | $1.1 million |
| [Neuroone Med Technologies Co](https://specstream.ai/data/institutional-holders/neuroone-med-technologies-co-64130m308) | COM | 82,767 | $251,612 |
| [Enveric Biosciences Inc](https://specstream.ai/data/institutional-holders/enveric-biosciences-inc-29405e505) | COM SHS | 180,000 | $248,400 |
| [QT Imaging Hldgs Inc](https://specstream.ai/data/institutional-holders/qt-imaging-hldgs-inc-746962307) | COM | 15,236 | $62,011 |

## Positions exited in Q2 2026

34 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Corcept Therapeutics Inc](https://specstream.ai/data/institutional-holders/corcept-therapeutics-inc-218352102) | COM | 674,759 | $27.2 million |
| [Livanova PLC](https://specstream.ai/data/institutional-holders/livanova-plc-g5509l101) | SHS | 421,615 | $26.8 million |
| [Embecta Corp](https://specstream.ai/data/institutional-holders/embecta-corp-29082k105) | COMMON STOCK | 1,847,850 | $16.3 million |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 135,800 | $15.1 million |
| [Haemonetics Corp Mass](https://specstream.ai/data/institutional-holders/haemonetics-corp-mass-405024100) | COM | 220,672 | $12.4 million |
| [Teleflex Incorporated](https://specstream.ai/data/institutional-holders/teleflex-incorporated-879369106) | COM | 94,800 | $11.3 million |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 194,226 | $11 million |
| [Structure Therapeutics Inc](https://specstream.ai/data/institutional-holders/structure-therapeutics-inc-86366e106) | SPONSORED ADS | 209,093 | $10.1 million |
| [Biohaven LTD](https://specstream.ai/data/institutional-holders/biohaven-ltd-g1110e107) | COM | 1,163,926 | $9.8 million |
| [Monopar Therapeutics Inc](https://specstream.ai/data/institutional-holders/monopar-therapeutics-inc-61023l207) | COM NEW | 173,506 | $9.5 million |
| [Crinetics Pharmaceuticals in](https://specstream.ai/data/institutional-holders/crinetics-pharmaceuticals-in-22663k107) | COM | 249,887 | $9.1 million |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 268,986 | $8.5 million |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 1,506,525 | $8.3 million |
| [Quidelortho Corp](https://specstream.ai/data/institutional-holders/quidelortho-corp-219798105) | COM | 359,011 | $5.9 million |
| [Replimune Group Inc](https://specstream.ai/data/institutional-holders/replimune-group-inc-76029n106) | COM | 720,036 | $5.5 million |
| [Organon & Co](https://specstream.ai/data/institutional-holders/organon-co-68622v106) | COMMON STOCK | 865,908 | $5.2 million |
| [Disc Medicine Inc](https://specstream.ai/data/institutional-holders/disc-medicine-inc-254604101) | COM | 65,203 | $4.2 million |
| [Integra Lifesciences Hldgs C](https://specstream.ai/data/institutional-holders/integra-lifesciences-hldgs-c-457985208) | COM NEW | 383,140 | $3.6 million |
| Centene Corp Del | COM (put) | 100,000 | $3.3 million |
| [Proqr Thrapeutics N V](https://specstream.ai/data/institutional-holders/proqr-thrapeutics-n-v-n71542109) | SHS EURO | 1,954,715 | $3.2 million |
| [Shoulder Innovations Inc](https://specstream.ai/data/institutional-holders/shoulder-innovations-inc-82537j108) | COMMON STOCK | 210,641 | $3.1 million |
| [Kymera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kymera-therapeutics-inc-501575104) | COM | 32,235 | $2.7 million |
| [Context Therapeutics Inc](https://specstream.ai/data/institutional-holders/context-therapeutics-inc-21077p108) | COM | 917,922 | $2.4 million |
| [Hyperfine Inc](https://specstream.ai/data/institutional-holders/hyperfine-inc-44916k106) | COM CL A | 1,000,000 | $1.1 million |
| [Foghorn Therapeutics Inc](https://specstream.ai/data/institutional-holders/foghorn-therapeutics-inc-344174107) | COM | 122,889 | $587,409 |

## Also on SpecStream

- [Sio Capital Management, LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1482416/000121465926010311/0001214659-26-010311-index.htm)
- [Sio Capital Management, LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/sio-capital-management-llc-165989)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Vietnamese restaurants in New York, New York](https://specstream.ai/data/businesses/vietnamese-restaurants/new-york-new-york-united-states)
- [Office supply stores in New York, New York](https://specstream.ai/data/businesses/office-supply-stores/new-york-new-york-united-states)
- [Escrow companies in New York, New York](https://specstream.ai/data/businesses/escrow-companies/new-york-new-york-united-states)
- [Asian fusion restaurants in New York, New York](https://specstream.ai/data/businesses/asian-fusion-restaurants/new-york-new-york-united-states)
- [Printing companies in New York, New York](https://specstream.ai/data/businesses/printing-companies/new-york-new-york-united-states)
- [Health food restaurants in New York, New York](https://specstream.ai/data/businesses/health-food-restaurants/new-york-new-york-united-states)
